• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of pnasPNASInfo for AuthorsSubscriptionsAboutThis Article
Proc Natl Acad Sci U S A. Oct 24, 1995; 92(22): 10197–10201.

Mycoplasmas and oncogenesis: persistent infection and multistage malignant transformation.


Oncogenic potential of human mycoplasmas was studied using cultured mouse embryo cells, C3H/10T1/2 (C3H). Mycoplasma fermentans and Mycoplasma penetrans, mycoplasmas found in unusually high frequencies among patients with AIDS, were examined. Instead of acute transformation, a multistage process in promotion and progression of malignant cell transformation with long latency was noted; after 6 passages (1 wk per passage) of persistent infection with M. fermentans, C3H cells exhibited phenotypic changes with malignant characteristics that became progressively more prominent with further prolonged infection. Up to at least the 11th passage, all malignant changes were reversible if mycoplasmas were eradicated by antibiotic treatment. Further persistent infection with the mycoplasmas until 18 passages resulted in an irreversible form of transformation that included the ability to form tumors in animals and high soft agar cloning efficiency. Whereas chromosomal loss and translocational changes in C3H cells infected by either mycoplasma during the reversible stage were not prominent, the onset of the irreversible phase of transformation coincided with such karyotypic alteration. Genetic instability--i.e., prominent chromosomal alteration of permanently transformed cells--was most likely caused by mutation of a gene(s) responsible for fidelity of DNA replication or repair. Once induced, chromosomal alterations continued to accumulate both in cultured cells and in animals without the continued presence of the transforming microbes. Mycoplasma-mediated multistage oncogenesis exhibited here shares many characteristics found in the development of human cancer.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.4M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Wright K. Mycoplasmas in the AIDS spotlight. Science. 1990 May 11;248(4956):682–683. [PubMed]
  • Wang RY, Shih JW, Grandinetti T, Pierce PF, Hayes MM, Wear DJ, Alter HJ, Lo SC. High frequency of antibodies to Mycoplasma penetrans in HIV-infected patients. Lancet. 1992 Nov 28;340(8831):1312–1316. [PubMed]
  • Wang RY, Shih JW, Weiss SH, Grandinetti T, Pierce PF, Lange M, Alter HJ, Wear DJ, Davies CL, Mayur RK, et al. Mycoplasma penetrans infection in male homosexuals with AIDS: high seroprevalence and association with Kaposi's sarcoma. Clin Infect Dis. 1993 Oct;17(4):724–729. [PubMed]
  • Lindsey JR, Baker HJ, Overcash RG, Cassell GH, Hunt CE. Murine chronic respiratory disease. Significance as a research complication and experimental production with Mycoplasma pulmonis. Am J Pathol. 1971 Sep;64(3):675–708. [PMC free article] [PubMed]
  • Paton GR, Jacobs JP, Perkins FT. Chromosome changes in human diploid-cell cultures infected with Mycoplasma. Nature. 1965 Jul 3;207(992):43–45. [PubMed]
  • Macpherson I, Russell W. Transformations in hamster cells mediated by mycoplasmas. Nature. 1966 Jun 25;210(5043):1343–1345. [PubMed]
  • Kotani H, Phillips D, McGarrity GJ. Malignant transformation of NIH-3T3 and CV-1 cells by a helical mycoplasma, Spiroplasma mirum, strain SMCA. In Vitro Cell Dev Biol. 1986 Dec;22(12):756–762. [PubMed]
  • McGarrity GJ, Vanaman V, Sarama J. Cytogenetic effects of mycoplasmal infection of cell cultures: a review. In Vitro. 1984 Jan;20(1):1–18. [PubMed]
  • Reznikoff CA, Brankow DW, Heidelberger C. Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division. Cancer Res. 1973 Dec;33(12):3231–3238. [PubMed]
  • Han A, Elkind MM. Transformation of mouse C3H/10T1/2 cells by single and fractionated doses of X-rays and fission-spectrum neutrons. Cancer Res. 1979 Jan;39(1):123–130. [PubMed]
  • Kennedy AR, Fox M, Murphy G, Little JB. Relationship between x-ray exposure and malignant transformation in C3H 10T1/2 cells. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7262–7266. [PMC free article] [PubMed]
  • Bryant PE, Riches AC. Oncogenic transformation of murine C3H 10T1/2 cells resulting from DNA double-strand breaks induced by a restriction endonuclease. Br J Cancer. 1989 Dec;60(6):852–854. [PMC free article] [PubMed]
  • Lo SC, Shih JW, Newton PB, 3rd, Wong DM, Hayes MM, Benish JR, Wear DJ, Wang RY. Virus-like infectious agent (VLIA) is a novel pathogenic mycoplasma: Mycoplasma incognitus. Am J Trop Med Hyg. 1989 Nov;41(5):586–600. [PubMed]
  • Hayes MM, Foo HH, Kotani H, Wear DJ, Lo SC. In vitro antibiotic susceptibility testing of different strains of Mycoplasma fermentans isolated from a variety of sources. Antimicrob Agents Chemother. 1993 Nov;37(11):2500–2503. [PMC free article] [PubMed]
  • Hayes MM, Foo HH, Timenetsky J, Lo SC. In vitro antibiotic susceptibility testing of clinical isolates of Mycoplasma penetrans from patients with AIDS. Antimicrob Agents Chemother. 1995 Jun;39(6):1386–1387. [PMC free article] [PubMed]
  • Dawson MS, Hayes MM, Wang RY, Armstrong D, Kundsin RB, Lo SC. Detection and isolation of Mycoplasma fermentans from urine of human immunodeficiency virus type 1-infected patients. Arch Pathol Lab Med. 1993 May;117(5):511–514. [PubMed]
  • Grau O, Kovacic R, Griffais R, Montagnier L. Development of a selective and sensitive polymerase chain reaction assay for the detection of Mycoplasma pirum. FEMS Microbiol Lett. 1993 Feb 1;106(3):327–333. [PubMed]
  • Wurster DH. Mouse chromosomes identified by trypsin-Giemsa (T-G) banding. Cytogenetics. 1972;11(5):379–387. [PubMed]
  • Bishop JM. Molecular themes in oncogenesis. Cell. 1991 Jan 25;64(2):235–248. [PubMed]
  • Cavenee WK, Scrable HJ, James CD. Molecular genetics of human cancer predisposition and progression. Mutat Res. 1991 Apr;247(2):199–202. [PubMed]
  • Stanbridge EJ. Human tumor suppressor genes. Annu Rev Genet. 1990;24:615–657. [PubMed]
  • Weinberg RA. Tumor suppressor genes. Science. 1991 Nov 22;254(5035):1138–1146. [PubMed]
  • Lothe RA, Peltomäki P, Meling GI, Aaltonen LA, Nyström-Lahti M, Pylkkänen L, Heimdal K, Andersen TI, Møller P, Rognum TO, et al. Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res. 1993 Dec 15;53(24):5849–5852. [PubMed]
  • Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, Orentreich N, Vogelman JH, Friedman GD. Helicobacter pylori infection and gastric lymphoma. N Engl J Med. 1994 May 5;330(18):1267–1271. [PubMed]
  • Blaser MJ, Parsonnet J. Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest. 1994 Jul;94(1):4–8. [PMC free article] [PubMed]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...